糖尿病患者白内障超声乳化术临床观察

Phacoemulsification on cataract patients with diabetes

目的:探讨糖尿病患者白内障超声乳化联合人工晶体植入的疗效。方法:选择糖尿病患者空腹血糖<10 mmol/L行白内障超声乳化手术62例84只眼,对照组为同期随机抽取的非糖尿病患者行白内障超声乳化66例84眼,观察术中、术后并发症及术后视力,随访时间为4个月～6年。结果:两组患者术后视力均有明显提高,糖尿病组视力差的原因主要由增殖性糖尿病性视网膜病变所致。人工晶体表面色素沉着、前房渗出膜形成、新生血管性青光眼等并发症的发生率糖尿病组高于正常对照组。结论:糖尿病患者只要有效控制血糖,行白内障超声乳化联合人工晶体植入术是安全有效的手术方法。为糖尿病网膜病变行激光治疗提供了条件,增殖性视网膜病变是影响术后视力的主要原因。

Objective：To investigate the validity of phacoemulsification and intraocular lens （IOL） implantation on cataract patients with diabetes. Methods：Sixty-two patients （84 eyes） with cataract and diabetes with empty stomach blood sugar〈10 mmol/L,the control group 66 patients （84 eyes） with cataract only for same time,lntra-and-post-operation complications were recorded,The visual acuity of patients after operation was also examined in detail, the revisit time was 4 months -6 years. Results：The visual acuity of two group of patient obviously improved compared with that before operation. The man reason of low visual acuity after surgery was diabetic retinopathy. The comphcation of the cataract patients with diabetes in intraocular lens plane pigmentation,the anterior chamber exudative membrane formation,newborn vascular glaucoma,was higher than that of the normal group. Conclusion：The phacoemnlsification on cataract patients with diabetes which would improve their blood sugar, is a safe, effective and practical surgical treatment for cataract patients with diabetes,and would also make fundus fluorescence and photocoagulation possible for diabetes patients.Diabetic retinopathy is the main reason of low visual acuity after surgery.